Modes of mediated exodus of amino acids from the Ehrlich ascites tumor cell.
D000409:Alanine / Q000378:metabolism; D000596:Amino Acids / Q000037:antagonists & inhibitors / Q000378:metabolism* / Q000494:pharmacology; D000621:Aminoisobutyric Acids / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D001202:Ascitic Fluid; D001693:Biological Transport, Active / Q000187:drug effects; D001952:Bridged-Ring Compounds / Q000378:metabolism; D002286:Carcinoma, Ehrlich Tumor / Q000378:metabolism*; D003864:Depression, Chemical; D004140:Dinitrophenols / Q000494:pharmacology; D005998:Glycine / Q000378:metabolism; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D008239:Lysine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D010649:Phenylalanine / Q000378:metabolism / Q000494:pharmacology; D012964:Sodium; D013237:Stereoisomerism; D013997:Time Factors; D014316:Tritium
D000596:Amino Acids; D000621:Aminoisobutyric Acids; D001952:Bridged-Ring Compounds; D004140:Dinitrophenols; D014316:Tritium; D010649:Phenylalanine; D012964:Sodium; D008239:Lysine; D000409:Alanine; D005998:Glycine